First report of Lophomonas infection in a patient with AML-2 from Qeshm Island, Persian Gulf, southern Iran.
Ali SharifpourHossein ZarrinfarMahdi FakharZakaria ZakariaeiMostafa SoleymaniElham Sadat BanimostafaviMaryam NakhaeiPublished in: Respirology case reports (2022)
Immunocompromised patients are frequently more susceptible to pathogens such as protozoa. For the first time, we report a case of pulmonary lophomoniasis in a known case of acute myeloid leukaemia (AML-2) from Qeshm Island, Persian Gulf, southern Iran. Diagnosis of lophomoniasis was confirmed using microscopy and molecular examinations of bronchoalveolar lavage fluid. She was completely treated with metronidazole (500 mg three times a day for 3 weeks). We conclude that immunocompromised patients with unjustified respiratory disorders should be screened for Lophomonas infection.
Keyphrases
- acute myeloid leukemia
- respiratory failure
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- single molecule
- pulmonary hypertension
- liver failure
- bone marrow
- peritoneal dialysis
- dendritic cells
- high resolution
- allogeneic hematopoietic stem cell transplantation
- high throughput
- immune response
- high speed
- drug induced
- multidrug resistant
- hepatitis b virus
- single cell